Summary of Key Points Core Viewpoint - Next week, 47 listed companies will face the unlocking of restricted shares, with a total market value of approximately 78.547 billion yuan [2]. Company Performance - Wanjian Medical: The company will unlock 40.66144 million shares, with a market value of 15.943 billion yuan. In the first half of the year, it achieved revenue of 5.296 billion yuan, a year-on-year increase of 31.31%, and a net profit of 492 million yuan, up 28.07% [4]. - Kangguan Technology: The company will unlock 45.86262 million shares, with a market value of 10.59 billion yuan. It reported revenue of approximately 6.935 billion yuan, a year-on-year increase of 5.06%, and a net profit of 384 million yuan, down 6.03% [4]. - Zhejiang Zhengte: The company will unlock 76.9215 million shares, accounting for 69.93% of its total share capital, with a market value of 3.793 billion yuan. It achieved revenue of 1.042 billion yuan, a year-on-year increase of 38.63%, and a net profit of 70.5088 million yuan, up 56.03% [8]. Unlocking Scale and Impact - Among the 47 companies, 17 have a market value of unlocked shares exceeding 1 billion yuan. Wanjian Medical and Kangguan Technology lead with over 10 billion yuan each [2]. - 18 companies have an unlocking ratio exceeding 10%, with Zhejiang Zhengte, Wanjian Medical, and Kangguan Technology having ratios above 60% [6]. Future Outlook - Wanjian Medical aims to continue its growth trajectory by focusing on high-quality products and maintaining a dual-track strategy in medical and consumer sectors [4]. - Kangguan Technology's revenue growth is attributed to the expansion of its self-owned brand in overseas markets, with a significant contribution from new technology innovations [5]. Unlocking Types - 22 of the 47 stocks have unlocking types classified as equity incentive general shares or restricted shares, indicating a diverse range of unlocking scenarios [10].